Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1N acetyl cysteine1件: Cysteine---1件: 19
2N Acetyl L Leucine1件: Leucine1件: D00030 --1件: 19
3N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate1件: Guanidine---1件: 113
4N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: D02601 --1件: 127
5N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: D02601 --1件: 127
6N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: D02601 --1件: 127
7N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate1件: Guanidine---1件: 113
8N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----1件: 299
9N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----1件: 299
10N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide----1件: 49
11N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----1件: 299
12N-0923----1件: 6
13N-3 LC-PUFA----1件: 46
14N-3 Polyunsaturated Fatty Acids----1件: 96
15N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide2件: Acetamide,
Pyrazole		---1件: 154
16N-acetyl cysteine1件: Cysteine---6件: 13, 34, 85, 88, 296, 310
17N-Acetyl Cysteine (NAC)1件: Cysteine---1件: 90
18N-acetyl-cysteine1件: Cysteine---1件: 84
19N-Acetyl-L Leucine1件: Leucine1件: D00030 --1件: 19
20N-Acetyl-L-Leucine2件: L-Acetylleucine,
Leucine		1件: D00030 --2件: 19, 65
21N-acetylcystein----1件: 299
22N-Acetylcysteine1件: Acetylcysteine1件: D00221 --13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337
23N-acetylcysteine (NAC)1件: Acetylcysteine1件: D00221 --2件: 51, 299
24N-acetylcysteine capsule1件: Acetylcysteine1件: D00221 --1件: 6
25N-acetylcysteine syrup1件: Acetylcysteine1件: D00221 --1件: 53
26N-Acetylcysteine, (NAC)1件: Acetylcysteine1件: D00221 --1件: 85
27N-acetylgalactosamine 4-sulfatase----1件: 19
28N-acetylneuraminic acid----1件: 30
29N-Carbamylglutamate1件: Carglumic acid1件: D07130 1件: CPS1 💬6件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬2件: 245, 246
30N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium----1件: 28
31N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----1件: 13
32N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate2件: Acetate,
Somatotropin		---1件: 265
33N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium----1件: 96
34N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium----1件: 96
35N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----1件: 11
36N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE5件: Aluminium,
Aluminum hydroxide,
Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein,
Hydroxide ion		1件: D02416 --1件: 11
37N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14
38N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM1971件: Corynebacterium diphtheriae CRM197 protein---1件: 13
39N.a.----10件: 3, 6, 8, 13, 46, 96, 97, 240, 256, 271
40N.d.----1件: 97
41N02BG10----1件: 13
42N03AX12----1件: 13
43N04BA----1件: 6
44N04BC07----1件: 6
45N04BD02----1件: 6
46N06DX01----1件: 13
47N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE----2件: 5, 17
48N6022----1件: 299
49N91115----1件: 299
50Na----3件: 36, 46, 85
51Na18F----1件: 13
52Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)1件: Sirolimus1件: D00753 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 86
53NABILONE1件: Nabilone1件: D05099 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 6, 13, 127
54Nabilone 0.25 mg1件: Nabilone1件: D05099 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6
55Nabiximols1件: Nabiximols1件: D09317 --1件: 13
56Nabiximols - Sativex2件: Dronabinol,
Nabiximols		2件: D00306 ,
D09317 		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13
57NAC----4件: 51, 85, 90, 299
58NAC effervescent tablets----1件: 90
59NaCl----1件: 227
60NaCl 0.9%----1件: 39
61Nacom----1件: 6
62NACOM 100----1件: 6
63NACOM levodopa+cardidopa1件: Levodopa1件: D00059 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
64Nacystelyn----1件: 299
65Nacystelyn®----1件: 299
66NADH1件: NADH---1件: 302
67Nadolol1件: Nadolol1件: D00432 2件: ADRB1,
ADRB2 💬		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
68Naglazyme1件: Galsulfase1件: D06565 1件: ARSB 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
69Naglazyme (galsulfase)1件: Galsulfase1件: D06565 1件: ARSB 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
70Naglazyme®1件: Galsulfase1件: D06565 1件: ARSB 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
71NAL----2件: 6, 299
72Nalbuphine1件: Nalbuphine1件: D08246 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
73Nalbuphine ER1件: Nalbuphine1件: D08246 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
74Nalbuphine Extended-Realease (ER) Tablets1件: Nalbuphine1件: D08246 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
75Nalbuphine Extended-Release (ER) Tablets1件: Nalbuphine1件: D08246 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
76NALBUPHINE HYDROCHLORIDE1件: Nalbuphine1件: D08246 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
77Nalmefene1件: Nalmefene1件: D05111 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
78Naloxone1件: Naloxone1件: D08249 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 226
79NALOXONE HYDROCHLORIDE1件: Naloxone1件: D08249 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
80NALOXONE HYDROCHLORIDE DIHYDRATE1件: Naloxone1件: D08249 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
81Naltrexone1件: Naltrexone1件: D05113 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226
82NALTREXONE CLORIDRATO1件: Naltrexone1件: D05113 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 10
83NALTREXONE HYDROCHLORIDE1件: Naltrexone1件: D05113 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬8件: 10, 40, 41, 42, 43, 44, 45, 96
84Naltrexone-HCl1件: Naltrexone1件: D05113 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 96
85NAMILUMAB1件: Namilumab---2件: 46, 84
86Namilumab (MT203)1件: Namilumab---1件: 46
87Namisol----2件: 13, 298
88Namuscla1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114
89NAND (Neoandrographolide)----1件: 97
90Nandrolone1件: Nandrolone1件: D08250 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 60, 85
91Nandrolone Decanoate2件: Nandrolone,
Nandrolone decanoate		2件: D00955 ,
D08250 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 60, 85
92Nanobody directed towards the human A1 domain of von Willebrand factor1件: Von Willebrand factor human---1件: 64
93Nanobubble drink----1件: 46
94Nanocort----3件: 13, 46, 97
95Nanocurcumin----2件: 13, 271
96Nanogam----1件: 63
97Nanogam 100 mg/ml----1件: 65
98Nanogam® 50 mg/ml----1件: 65
99Nanoparticulated Rebamipide1件: Rebamipide1件: D01121 --1件: 46
100Nanosuspension)----1件: 113
101Nap----2件: 96, 240
102NaPBA----1件: 251
103Naprosyn1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
104Naprosyn 500 mg1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
105Naprosysn----1件: 271
106Naproxen1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 107, 271
107Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
108Naproxen 10 mg/kg1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
109Naproxen 500 mg tablets (PN 200 minus omeprazole)2件: Naproxen,
Omeprazole		2件: D00118 ,
D00455 		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271
110Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
111Naproxen oral suspension1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
112NAPROXEN SODIUM1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 107
113Naproxen sodium 550mg tablet1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
114Nardil1件: Phenelzine1件: D08349 2件: MAOA,
MAOB 💬		14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
115Narsoplimab1件: Narsoplimab1件: D11531 1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 66, 222
116Nasal Aztreonam1件: Aztreonam1件: D00240 --1件: 299
117Nasonex----1件: 98
118Nasopharyngeal swabs----1件: 46
119NATALIZUMAB1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬5件: 13, 15, 25, 46, 96
120Natalizumab (BG00002)1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
121Natalizumab (NTZ)1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
122Natalizumab (Tysabri)1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
123Natalizumab 300 MG in 15 ML Injection1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
124Natalizumab for IV Infusion1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
125Natalizumab for Subcutaneous Injection1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
126Natalizumab Injection [Tysabri]1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
127Natalizumab IV1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
128Natalizumab SC1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
129Natalizumab treatment1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
130National Drug Code: 59762-0074----1件: 81
131Natpar1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
132Natpara----1件: 235
133NATPARA/NATPAR1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
134Natriumchlorid1件: Sodium chloride1件: D02056 --1件: 288
135Natriumchlorid 0,9 %1件: Sodium chloride1件: D02056 --1件: 288
136Natriumklorid 9mg/ml----1件: 46
137Natriuretic peptide----1件: 276
138Natrunix----1件: 46
139Navocaftor----1件: 299
140NBI-5788----1件: 13
141NBI-74788----1件: 81
142NBI-77860----1件: 81
143NBI-827104----1件: 154
144NBMI----2件: 5, 17
145NBT-NM108----1件: 193
146NBT-NM108 (60 g/day)----1件: 13
147NBTX-001----1件: 6
148NC 1 cell therapy----1件: 117
149NC-503 (Anti-amyloidotic (AA) Agent)----1件: 46
150NCA 500mg----1件: 93
151Nd----6件: 2, 6, 13, 46, 51, 97
152ND-L02-s0201----1件: 85
153ND-L02-s0201 for injection----1件: 85
154ND0611----1件: 6
155ND0612----1件: 6
156ND0612 (Levodopa/Carbidopa solution)2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
157ND1421----1件: 6
158ND1587----1件: 6
159ND1589----1件: 6
160ND1590----1件: 6
161ND1702----1件: 6
162NDC0009-0436-01----1件: 78
163NDV-3A----1件: 65
164NE3107----1件: 6
165NEB/01-07----1件: 299
166Nebcin----1件: 299
167Nebcin (tobramycin)1件: Tobramycin1件: D00063 --1件: 299
168Nebcinal----1件: 299
169Nebcinal Tobi----1件: 299
170NEBCINE----1件: 299
171Nebicapone1件: Nebicapone---1件: 6
172Nebido----1件: 13
173Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection3件: Testosterone,
Testosterone undecanoate,
Undecanoic acid		2件: D00075 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13
174Nebivolol1件: Nebivolol1件: D05127 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 17, 85, 113, 167
175Nebivolol 5 mg1件: Nebivolol1件: D05127 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
176Nebulization of Amikacin during NIV (RR: 15 cycles/minute)1件: Amikacin1件: D02543 --1件: 299
177Nebulization of Amikacin during NIV (RR: 25 cycles/minute)1件: Amikacin1件: D02543 --1件: 299
178Nebulization tobramycin1件: Tobramycin1件: D00063 --1件: 299
179Nebulized combination ipratropium bromide with salbutamol2件: Ipratropium,
Salbutamol		1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
180Nebulized ipratropium bromide1件: Ipratropium---1件: 86
181Necator americanus----1件: 13
182Nedosiran----1件: 234
183Needle biopsy of the vastus lateralis muscle----1件: 113
184NEFECON----1件: 66
185Neflamapimod1件: Neflamapimod1件: D10959 4件: MAPK11,
MAPK12,
MAPK13,
MAPK14 💬		62件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬1件: 8
186NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 50
187NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA1件: Triethylenetetramine---1件: 50
188NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 50
189Nelfinavir1件: Nelfinavir1件: D08259 --3件: 49, 265, 331
190Nelfinavir mesylate1件: Nelfinavir1件: D08259 --1件: 265
191Nelotanserin1件: Nelotanserin1件: D09645 1件: HTR2A 💬5件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6
192Nelutri™----1件: 84
193Nemolizumab1件: Nemolizumab1件: D11080 1件: IL31RA 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 51
194Neo-ASA----1件: 251
195NEO-GAA----1件: 256
196Neo-Recormon----1件: 18
197NEOD001----1件: 28
198NeoFuse----1件: 70
199NeoGAA1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
200NeoGAA or avalglucosidase alfa1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
201Neomycin1件: Neomycin1件: D08260 --3件: 96, 97, 296
202Neophyr 1000ppm mol/mol----1件: 294
203Neoral1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 60, 97, 222
204Neoral Oral Solution1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 269
205Neoral Soft Gelatin Capsules2件: Cyclosporine,
Gelatin		3件: D00115 ,
D00184 ,
D06892 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 97, 269
206NeoRecormon----2件: 13, 18
207Neovasculgen----1件: 51
208Neramexane1件: Neramexane---1件: 13
209Neramexane mesylate1件: Neramexane---1件: 13
210Neratinib1件: Neratinib1件: D08950 3件: EGFR,
ERBB2,
ERBB4 💬		51件: Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬1件: 34
211Neridronic Acid1件: Neridronic Acid---1件: 6
212Nerispirdine1件: Nerispirdine---1件: 13
213Nerispirdine (HP184)1件: Nerispirdine---1件: 13
214Nerispirdine hydrochloride1件: Nerispirdine---1件: 13
215NERIXIA*IM EV 1F 25MG----1件: 6
216NERIXIA*INFUS IV CONC 2F 100MG----1件: 274
217Nerve block----1件: 46
218Nerve Growt Factor - 2.5S----1件: 90
219Nerve Growth Factor1件: Nerve Growth Factor---3件: 3, 53, 90
220Nessuno----1件: 96
221Neu-120----1件: 6
222Neumega (Oprelvekin, Interleukin 11, IL-11)1件: Oprelvekin1件: D05266 1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288
223NEUPOGEN----4件: 13, 28, 51, 285
224NEUPRO1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
225Neupro (Reference)1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
226NEUPRO 2 mg/24 h parche transdérmico1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
227Neupro 2 mg/24 h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
228Neupro 2mg/24 h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
229Neupro 2mg/24h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
230NEUPRO 4 mg/24 h parche transdérmico1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
231Neupro 4 mg/24 h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
232Neupro 4mg/24 h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
233Neupro 4mg/24h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
234Neupro 4Mg/24Hr Transdermal Patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
235NEUPRO 6 mg/24 h parche transdérmico1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
236Neupro 6 mg/24 h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
237Neupro 6mg/24 h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
238Neupro 6mg/24h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
239NEUPRO 8 mg/24 h parche transdérmico1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
240Neupro 8 mg/24 h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
241Neupro 8mg/24h transdermal patch1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
242NEUPRO*28CER 2MG/24H1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
243NEUPRO*28CER 4MG/24H1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
244NEUPRO*28CER 6MG/24H1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
245NEUPRO*28CER 8MG/24H1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
246NEUPRO*7CER 4MG/24H1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
247NEUPRO*7CER 6MG/24H1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
248NEUPRO*7CER 8MG/24H1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
249Neupro®1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
250Neupro® 8 mg/24 h1件: Rotigotine1件: D05768 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
251Neuraceq1件: Florbetaben (18F)---1件: 6
252NEUROASPIS PLP10®----1件: 13
253NEUROBLOC1件: Botulinum toxin type B1件: D02735 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6
254NeuroEPO----1件: 6
255Neurological evaluation----1件: 25
256NEURONTIN1件: Gabapentin1件: D00332 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13
257Neurontin 300 mg hard capsule1件: Gabapentin1件: D00332 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13
258NeuroVax1件: NeuroVax---1件: 13
259NeuroVax 300ug/mL Dose for IM Injection1件: NeuroVax---1件: 13
260Neurpro----1件: 6
261Nevanimibe1件: Nevanimibe1件: D11300 --2件: 75, 81
262Nevanimibe hydrochloride1件: Nevanimibe1件: D11300 --2件: 75, 81
263Nevirapine1件: Nevirapine1件: D00435 --1件: 265
264New formulation adalimumab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
265New Formulation Etanercept1件: Etanercept1件: D00742 2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
266New Formulation of rebif - human interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
267New thermo stable formulation of epoprostenol sodium1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
268NewGam----3件: 14, 63, 65
269Newnorm----1件: 65
270Nexavar1件: Sorafenib1件: D08524 8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34
271Nexavar (BAY 43-9006) (Sorafenib)1件: Sorafenib1件: D08524 8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34
272Nexium1件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
273Nexium (esomeprazole magnesium)2件: Esomeprazole,
Magnesium		1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 298
274Nexium 201件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
275Next generation sequencing----1件: 171
276NFC-1----1件: 203
277NFX-179 Gel----1件: 34
278NG-Monomethyl-L-arginine2件: Arginine,
Tilarginine		1件: D02982 --1件: 67
279Ng-monomethyl-L-arginine (drug)3件: Arginine,
L-arginine,
Tilarginine		1件: D02982 --1件: 67
280Ngenla1件: Somatrogon1件: D10990 --1件: 78
281NGENLA (Somatrogon)1件: Somatrogon1件: D10990 --1件: 78
282NGM282----2件: 93, 94
283NGN-101----1件: 19
284NGX2671件: NGX267---1件: 53
285NI-0101----1件: 46
286NI-03----1件: 298
287NI-0401 (anti-CD3 mAB)1件: Muromonab---1件: 96
288NI-0501----1件: 107
289NI-071----1件: 46
290NI-0801----1件: 93
291Niacin1件: Niacin1件: D00049 --2件: 6, 78
292Niacin First1件: Niacin1件: D00049 --1件: 78
293Niacinamide1件: Nicotinamide1件: D00036 --3件: 5, 6, 67
294Nicardipine1件: Nicardipine1件: D08270 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 70, 86
295Niclosamide1件: Niclosamide1件: D00436 --2件: 46, 97
296Nicolon----1件: 97
297Nicorette 10mg/ 16 h1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6
298Nicorette 15 mg/ 16 h1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6
299Nicorette 5 mg/ 16 h1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6
300Nicotinamid riboside----1件: 13
301Nicotinamide1件: Nicotinamide1件: D00036 --8件: 2, 6, 18, 49, 97, 107, 162, 191
302Nicotinamide riboside2件: Nicotinamide,
Nicotinamide riboside		1件: D00036 --5件: 2, 6, 18, 97, 191
303Nicotinamide Riboside Chloride3件: Chloride ion,
Nicotinamide,
Nicotinamide riboside		1件: D00036 --1件: 97
304NICOTINE1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬3件: 6, 13, 84
305Nicotine dependence1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 13
306Nicotine gum1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6
307Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6
308Nicotine patch1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬2件: 6, 84
309Nicotine transdermal patch1件: Nicotine1件: D03365 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6
310Nicotinell----1件: 6
311Nicotinell 17,5 mg/24-Stunden-Pflaster----1件: 6
312Nicotinell 35 mg/24-Stunden-Pflaster----1件: 6
313Nicotinic acid1件: Niacin1件: D00049 --1件: 79
314Nifedipine1件: Nifedipine1件: D00437 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 50, 81
315Nifurtimox1件: Nifurtimox1件: D00833 --1件: 65
316Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d2件: Eflornithine,
Nifurtimox		2件: D00833 ,
D07883 		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65
317Nifurtimox-Eflronithine Combination Treatment (NECT)1件: Nifurtimox1件: D00833 --1件: 65
318Nilotinib1件: Nilotinib1件: D08953 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬5件: 6, 8, 34, 51, 86
319Nilotinib (Tasigna)1件: Nilotinib1件: D08953 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 51
320Nilotinib 150 MG1件: Nilotinib1件: D08953 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 8
321Nilotinib 150mg oral capsule [Tasigna]1件: Nilotinib1件: D08953 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6
322Nilotinib 300mg oral capsule [Tasigna]1件: Nilotinib1件: D08953 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6
323Nilotinib 50 mg1件: Nilotinib1件: D08953 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86
324NILOTINIB HYDROCHLORIDE MONOHYDRATE1件: Nilotinib1件: D08953 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34
325Nilvadipine1件: Nilvadipine1件: D01908 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 90
326Nimenrix1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---2件: 50, 61
327Nimesulide1件: Nimesulide1件: D01049 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
328Ninlaro1件: Ixazomib1件: D10130 1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬2件: 13, 61
329NINTEDANIB1件: Nintedanib1件: D10481 8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬5件: 51, 85, 89, 227, 228
330Nintedanib 150 mg and 100 mg soft capsules1件: Nintedanib1件: D10481 8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 227
331Nintédanib----1件: 227
332NIP292 tablet----1件: 85
333NIP292 tablets----1件: 85
334Nipocalimab1件: Nipocalimab1件: D11666 1件: FCGRT 💬-6件: 11, 14, 46, 49, 53, 61
335Nitazoxanide1件: Nitazoxanide1件: D02486 --3件: 46, 96, 97
336Nitazoxanide 500Mg Oral Tablet1件: Nitazoxanide1件: D02486 --2件: 46, 97
337NITISINONE1件: Nitisinone1件: D05177 1件: HPD 💬5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬3件: 6, 164, 241
338Nitisinone 10 mg Tablet High Compritol1件: Nitisinone1件: D05177 1件: HPD 💬5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241
339Nitisinone Baked Tablet1件: Nitisinone1件: D05177 1件: HPD 💬5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241
340Nitrate1件: Nitrate1件: D02313 --4件: 58, 67, 113, 299
341Nitrate-depleted beetroot juice1件: Nitrate1件: D02313 --1件: 67
342NITRIC OXIDE1件: Nitric Oxide1件: D00074 --7件: 85, 86, 88, 210, 251, 294, 299
343Nitric Oxide 160 ppm1件: Nitric Oxide1件: D00074 --1件: 299
344Nitric Oxide for inhalation1件: Nitric Oxide1件: D00074 --2件: 86, 299
345Nitric Oxide generated by the GeNO nitrosyl delivery system1件: Nitric Oxide1件: D00074 --1件: 86
346Nitric Oxide plus Oxygen2件: Nitric Oxide,
Oxygen		2件: D00003 ,
D00074 		--1件: 86
347Nitric oxide supplement1件: Nitric Oxide1件: D00074 --1件: 251
348Nitrite1件: Nitrite---2件: 58, 86
349Nitrofurantoin1件: Nitrofurantoin1件: D00439 --1件: 13
350Nitrogen1件: Nitrogen1件: D00083 --5件: 5, 6, 17, 211, 299
351Nitroglycerin1件: Nitroglycerin1件: D00515 --1件: 51
352Nitroglycerin Ointment 2%1件: Nitroglycerin1件: D00515 --1件: 51
353Nitroglycerine1件: Nitroglycerin1件: D00515 --2件: 46, 51
354Nitroglycerine gel1件: Nitroglycerin1件: D00515 --1件: 51
355Nitroprusside1件: Nitroprusside---1件: 51
356Nitrosyl1件: Nitric Oxide1件: D00074 --1件: 86
357Nitrous Oxide1件: Nitrous oxide1件: D00102 --1件: 34
358NiuBangZi pill----1件: 46
359Nivolumab1件: Nivolumab1件: D10316 1件: PDCD1 💬3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159
360NIZORAL1件: Ketoconazole1件: D00351 1件: CYP17A1 💬6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75
361NK Cells1件: Natural Killer Cell---1件: 26
362Nle4,D-Phe7]-a-melanocyte stimulating hormone or NDP-a-MSH----1件: 254
363Nle4-D-Phe7-alpha-MSH----1件: 254
364NLX-112----1件: 6
365NLY01----1件: 6
366NM8074----2件: 62, 109
367NMDA1件: Ketamine1件: D08098 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
368NN 1841----1件: 288
369NN-220----1件: 78
370NN1841----1件: 288
371NN8630----1件: 78
372NN8640----1件: 78
373NNC 0109-0000-0012----1件: 46
374NNC 0141-0000-0100----1件: 46
375NNC 0142-0000-0002----2件: 46, 96
376NNC 0151-0000-0000----2件: 46, 49
377NNC 126-0083----1件: 78
378NNC 142-0002----1件: 46
379NNC0109-0012----1件: 46
380NNC0114-0000-0005----1件: 46
381NNC0114-0006----3件: 46, 49, 96
382NNC0142-0000-0002----1件: 96
383NNC0142-0002----1件: 46
384NNC0151-0000-0000----1件: 46
385NNC0195-0092----1件: 78
386NNC0195-0092 10 mg/1.5 ml PDS290-10----1件: 78
387NNC0195-0092 15 mg/1.5 ml PDS290-15----1件: 78
388NNC0195-0092 5 mg/1.5 ml PDS290-10----1件: 78
389NNC0195-0092 DP 6.7 mg ml 3 ml cartridge----1件: 78
390NNC0195-0092 PDS290 10 mg-1.5 ml----1件: 78
391NNC0195-0092 PDS290 10 mg/1.5 ml----1件: 78
392NNC0215-0384----2件: 46, 162
393NNC109-0012----1件: 46
394NNC126-00831件: Somatropin pegol---1件: 78
395NNC142-0002----1件: 96
396NNC151-0000----1件: 46
397NNZ-2566----2件: 156, 206
398NNZ-25911件: NNZ-2591---1件: 201
399NO----9件: 6, 46, 58, 62, 86, 97, 222, 299, 321
400Nolpitantium Besylate----1件: 97
401NOMACOPAN1件: Nomacopan1件: D11473 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 162
402Nomacopan (rVA576)1件: Nomacopan1件: D11473 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 162
403Nomegestrol1件: Nomegestrol1件: D07222 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13
404Nomegestrol acetate3件: Acetate,
Nomegestrol,
Nomegestrol acetate		2件: D07222 ,
D08281 		1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13
405Non applicabile----4件: 13, 49, 51, 256
406Non applicable----2件: 10, 19
407Non as of yet----1件: 97
408Non ATG Conditioning regimen----1件: 60
409NON COMMERCIAL----1件: 75
410Non disponibile----1件: 201
411Non intervention-Genetic testing----1件: 6
412Non invasive prenatal diagnosis----3件: 8, 113, 206
413NON PROPIETRY, THEREFORE N/A----1件: 51
414Non-anti-TNF biologics----2件: 46, 271
415Non-biologic anti-rheumatic drugs----1件: 46
416Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)----1件: 46
417Non-Biologic DMARDs----3件: 46, 86, 107
418Non-biological DMARDs----1件: 46
419Non-enteric coated pancreatic enzyme preparation----1件: 298
420Non-myeloablative Hematopoietic Stem Cell Transplantation----1件: 93
421Non-nucleoside reverse transcriptase inhibitors----1件: 265
422Non-pegylated interferon----1件: 13
423Non-steroidal anti-inflammatory drug----1件: 46
424Non-steroidal anti-inflammatory drug (NSAID)----1件: 46
425Non-steroidal anti-inflammatory drugs----1件: 46
426Non-steroidal anti-inflammatory drugs (NSAIDs)----1件: 107
427Non-TNFi-biologic class----1件: 46
428Nonbiologic DMARDs of investigator's choice----1件: 46
429None----20件: 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337
430None as of yet1件: Interleukin-1 alpha, human recombinant---1件: 46
431None assigned1件: Interleukin-1 alpha, human recombinant---2件: 231, 299
432None at this time1件: Interleukin-1 alpha, human recombinant---2件: 96, 140
433None given1件: Interleukin-1 alpha, human recombinant---1件: 97
434None yet1件: Interleukin-1 alpha, human recombinant---2件: 51, 222
435Norantipyrine----1件: 2
436Nordilet®----1件: 78
437Norditropin1件: Somatotropin---2件: 78, 195
438Norditropin 24 IU1件: Somatotropin---1件: 195
439Norditropin FlexPro 10 mg1件: Somatotropin---1件: 78
440Norditropin FlexPro 10 mg/1.5 ml1件: Somatotropin---1件: 78
441Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen1件: Somatotropin---1件: 195
442Norditropin FlexPro 5 mg/1.5 mL1件: Somatotropin---1件: 78
443Norditropin FlexPro 5mg/1.5 ml1件: Somatotropin---1件: 78
444Norditropin Growth Hormone1件: Somatotropin---1件: 78
445Norditropin NordiFlex®----1件: 78
446Norditropin NordiFlex® 10 mg/1.5 ml1件: Somatotropin---1件: 78
447Norditropin NordiFlex® 10mg/1.5 ml1件: Somatotropin---1件: 78
448Norditropin Simplex1件: Somatotropin---1件: 78
449Norditropin SimpleXx----5件: 3, 78, 107, 193, 195
450Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)1件: Somatotropin---1件: 78
451Norditropin SimpleXx (growth hormone)1件: Somatotropin---1件: 78
452Norditropin SimpleXx 10 mg1件: Somatotropin---1件: 78
453Norditropin SimpleXx 15 mg/1.5 ml1件: Somatotropin---1件: 3
454Norditropin SimpleXx 5mg/1.5ml1件: Somatotropin---2件: 78, 107
455Norditropine simplex----1件: 238
456Norditropin®----2件: 78, 195
457Norditropin® FlexPro®----1件: 78
458Norditropin® FlexPro® pen----1件: 78
459Norditropin® SimpleXx® 5 mg/1.5ml1件: Somatotropin---1件: 78
460Norepinephrine1件: Norepinephrine1件: D00076 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296
461Norepinephrine Bitartrate1件: Norepinephrine1件: D00076 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 296
462Norethindrone1件: Norethisterone1件: D00182 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299
463Norgestimate1件: Norgestimate1件: D05209 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 299
464Normal human immunoglobulin G1件: Human immunoglobulin G---1件: 65
465Normal Saline----18件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299
466Normal Saline 0.9% Infusion Solution----1件: 22
467Normal Saline Enema----1件: 97
468Normal Saline for Injection----1件: 13
469Normal saline instillation----1件: 226
470Normal saline IV, salt tablets----1件: 299
471Normal saline solution1件: Sodium chloride1件: D02056 --1件: 299
472Normal saline:----1件: 299
473Normix----1件: 96
474NORMIX*AD 12CPR RIV 200MG----1件: 96
475Norovirus -specific T-cell (NST) therapy----1件: 65
476Norphenazone1件: Edaravone1件: D01552 --1件: 2
477Norspan----1件: 46
478Northera1件: Droxidopa1件: D01277 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
479Nortriptyline1件: Nortriptyline1件: D08288 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 226
480Nortriptyline hydrochloride1件: Nortriptyline1件: D08288 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6
481Norucholic acid1件: norUrsodeoxycholic acid---2件: 93, 94
482Norucholic acid (NCA) 500 mg1件: norUrsodeoxycholic acid---1件: 93
483NorUDCA----1件: 94
484NorUDCA (Norursodeoxycholic acid)1件: norUrsodeoxycholic acid---1件: 94
485NorUrsodeoxycholic Acid1件: norUrsodeoxycholic acid---1件: 94
486Norursodeoxycholic acid, NCA1件: norUrsodeoxycholic acid---1件: 94
487Norvir1件: Ritonavir1件: D00427 --2件: 265, 299
488Norvir 100 mg film-coated tablets----1件: 299
489Novamin----1件: 299
490Novantrone1件: Mitoxantrone1件: D08224 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13
491NOVANTRONE*INF 2MG/ML 5ML1件: Mitoxantrone1件: D08224 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13
492Novartis Pharmaceuticals Corporation----1件: 13
493NOVATREX----1件: 13
494Novo Rapid----1件: 299
495Novo Rapid Insulin (Novonordisk)----1件: 299
496Novolin-R insulin----1件: 127
497NovoNorm 0.5 mg----1件: 299
498NovoNorm 1 mg----1件: 299
499NovoNorm 2 mg----1件: 299
500Novorapid / humalog short acting insulin----1件: 299
501NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----1件: 299
502NovoRapid Aspartate----1件: 299
503NOX-E36----1件: 49
504Noxafil1件: Posaconazole1件: D02555 --3件: 60, 65, 299
505NOXAFIL - 40 mg/ml oral suspension1件: Posaconazole1件: D02555 --1件: 299
506NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE1件: Posaconazole1件: D02555 --1件: 299
507NOXAFIL - oral suspension 40 mg/ml1件: Posaconazole1件: D02555 --1件: 299
508Noxafil 100 mg1件: Posaconazole1件: D02555 --1件: 299
509Noxafil 100 mg Tablets Gastro-Resistant1件: Posaconazole1件: D02555 --1件: 299
510Noxafil 40 mg/ml oral solution1件: Posaconazole1件: D02555 --1件: 65
511Noxafil Gastro resistant tablets1件: Posaconazole1件: D02555 --1件: 60
512Noxafil®1件: Posaconazole1件: D02555 --2件: 60, 299
513NP001----1件: 2
514NP031112----1件: 5
515NP031112 600mg----1件: 5
516NP031112 800mg----1件: 5
517NPB-01----3件: 13, 14, 162
518NPC transplantation----1件: 6
519NPC-02----1件: 171
520NPC-09----1件: 30
521NPC-12G gel----2件: 34, 158
522NPC-12Y gel----1件: 158
523NPC-14----1件: 113
524NPI-001----2件: 90, 303
525NPL-2009----1件: 206
526NPLATE1件: Romiplostim1件: D08990 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
527NPLATE 500 microgramos polvo para solución inyectable1件: Romiplostim1件: D08990 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
528NPSP 558----1件: 235
529NPSP558----1件: 235
530NR082 Injection----1件: 302
531NR2B NMDA Antagonist CP-101,606 (traxoprodil)1件: Ketamine1件: D08098 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
532NRTX-1001----1件: 141
533NS----1件: 2
534NS 2330----1件: 6
535NS-065/NCNP-01----1件: 113
536NS-089/NCNP-02----1件: 113
537NS-304----3件: 70, 86, 88
538NS-304 Placebo----2件: 70, 88
539NS2----1件: 160
540NS2330----1件: 6
541NSAID----1件: 271
542NSAIDs----4件: 46, 70, 107, 271
543NSAIDs (permitted,not necessary)----1件: 46
544NSAIDs and sulfasalazine1件: Sulfasalazine1件: D00448 --1件: 271
545NsNSAIDs----2件: 107, 271
546NSP001----1件: 96
547NT 101----4件: 5, 6, 7, 17
548NT-501----2件: 90, 303
549NT-I71件: Efineptakin alfa1件: D11957 --1件: 25
550NT-KO-003----1件: 13
551NTBC----1件: 241
552NTCELL Implantation----1件: 6
553NTLA-2001----1件: 28
554NU100----1件: 13
555NUCALA1件: Mepolizumab1件: D04923 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45
556Nucala 100 mg powder for solution for injection1件: Mepolizumab1件: D04923 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45
557NUCALA®1件: Mepolizumab1件: D04923 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44
558NuCel----1件: 70
559NucleomaxX----1件: 265
560Nucleoside analogue sparing HAART regimen----1件: 265
561Nucleoside reverse transcriptase inhibitors----1件: 265
562Nuedexta----1件: 2
563Null----16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271
564Nulojix1件: Belatacept1件: D03222 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
565NurOwn (MSC-NTF cells)----2件: 2, 13
566NurOwn® (MSC-NTF cells)----1件: 2
567Nursinersen----1件: 3
568NUSINERSEN1件: Nusinersen1件: D10881 1件: SMN2 💬-1件: 3
569Nusinersen Injectable Product1件: Nusinersen1件: D10881 1件: SMN2 💬-1件: 3
570NUSINERSEN SODIUM1件: Nusinersen1件: D10881 1件: SMN2 💬-1件: 3
571Nusinersen Treatments1件: Nusinersen1件: D10881 1件: SMN2 💬-1件: 3
572Nutraceutical Combination----1件: 96
573Nutridrink-Impact----1件: 299
574Nutrition supplement----1件: 97
575Nutrition treat----1件: 96
576Nutritional dietary intervention----2件: 96, 97
577Nutritional Formulation Containing Exogenous Ketones----1件: 201
578Nutritional Ketone Supplement----1件: 317
579Nutritional Supplement----1件: 90
580Nutritional supplementation standardized formula----1件: 78
581NUTROPIN1件: Somatotropin---1件: 78
582Nutropin AQ----4件: 78, 134, 193, 299
583Nutropin AQ [somatropin (DNA origin) injection]1件: Somatotropin---1件: 299
584NutropinAq----1件: 78
585NutropinAq 10 mg/2 ml1件: Somatotropin---1件: 78
586NutropinAq 10 mg/2 ml (30 UI)1件: Somatotropin---1件: 78
587NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable1件: Somatotropin---1件: 78
588NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung1件: Somatotropin---1件: 65
589NutropinAq 10mg/2ml solution for injection1件: Somatotropin---1件: 96
590NutropinAq®1件: Somatotropin---1件: 96
591Nuvion®)----1件: 97
592NV1205----1件: 20
593NVF233----1件: 13
594NW-1015----1件: 6
595NW-1015E, EMD 1195686, MSC2191632B----1件: 6
596NX-13 250 mg----1件: 97
597NX-13 250mg IR----1件: 97
598NX-13 500mg IR----1件: 97
599NX-13 500mg MR----1件: 97
600NX1011----1件: 86
601NYX-458----1件: 6
602Nébivolol----1件: 113